- Home
- IVDA vs XRTX Comparison
IVDA vs XRTX Comparison
Compare IVDA & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- XRTX
- Stock Information
- Founded
- IVDA 2003
- XRTX 2011
- Country
- IVDA United States
- XRTX Canada
- Employees
- IVDA N/A
- XRTX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- XRTX Pharmaceuticals and Biotechnology
- Sector
- IVDA Technology
- XRTX Health Care
- Exchange
- IVDA Nasdaq
- XRTX Nasdaq
- Market Cap
- IVDA 4.3M
- XRTX 4.4M
- IPO Year
- IVDA N/A
- XRTX N/A
- Fundamental
- Price
- IVDA $1.33
- XRTX $0.67
- Analyst Decision
- IVDA
- XRTX
- Analyst Count
- IVDA 0
- XRTX 0
- Target Price
- IVDA N/A
- XRTX N/A
- AVG Volume (30 Days)
- IVDA 5.1M
- XRTX 6.0M
- Earning Date
- IVDA 11-13-2025
- XRTX 11-14-2025
- Dividend Yield
- IVDA N/A
- XRTX N/A
- EPS Growth
- IVDA N/A
- XRTX N/A
- EPS
- IVDA N/A
- XRTX N/A
- Revenue
- IVDA $7,142,302.00
- XRTX N/A
- Revenue This Year
- IVDA $340.48
- XRTX N/A
- Revenue Next Year
- IVDA N/A
- XRTX N/A
- P/E Ratio
- IVDA N/A
- XRTX N/A
- Revenue Growth
- IVDA 88.96
- XRTX N/A
- 52 Week Low
- IVDA $1.15
- XRTX $0.63
- 52 Week High
- IVDA $8.05
- XRTX $1.79
- Technical
- Relative Strength Index (RSI)
- IVDA 46.08
- XRTX 40.10
- Support Level
- IVDA $1.18
- XRTX $0.63
- Resistance Level
- IVDA $1.34
- XRTX $0.78
- Average True Range (ATR)
- IVDA 0.13
- XRTX 0.09
- MACD
- IVDA -0.01
- XRTX -0.03
- Stochastic Oscillator
- IVDA 30.86
- XRTX 5.13
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.